Low programmed cell death 5 expression is a prognostic factor in ovarian cancer.
Beijing, China. In Chin Med J (engl), May 2015
METHODS: Expression levels of PDCD5 mRNA and protein were examined in six ovarian cancer cell lines (SKOV3, CAOV3, ES2, OV1, 3AO, and HOC1A) and one normal ovarian epithelial cell line (T29) using reverse transcription polymerase chain reaction, Western blotting, and flow cytometry.
A purge and trap integrated microGC platform for chemical identification in aqueous samples.
Blacksburg, United States. In Analyst, 2014
The trapped compounds are desorbed from the μTPC by resistive heating using the on-chip heater and temperature sensor, are separated by a 2 m long, 80 μm wide, and 250 μm deep polydimethylsiloxane (OV-1) coated μGC separation column, and are identified using a micro-thermal conductivity detector (μTCD) monolithically integrated with the column.
PRL-2 increases Epo and IL-3 responses in hematopoietic cells.
Cleveland, United States. In Blood Cells Mol Dis, 2010
Mouse pre-B-cells transfected with human PRL-2 had higher growth responses to Epo or IL-3, shorter cell cycle, less Epo requirement for survival, more cell migration, less cell adhesion, change to an immature cell morphology, & more Bmi-1 expression.
PRL phosphatases as potential molecular targets in cancer.
Tucson, United States. In Mol Cancer Ther, 2005
The phosphatase of regenerating liver (PRL) family of phosphatases, consisting of PRL-1, PRL-2, and PRL-3, represents an intriguing group of proteins being validated as biomarkers and therapeutic targets in cancer.